Directly observed therapy reduces tuberculosis-specific mortality: A population-based follow-up study in taipei, taiwan

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Yen, Yung Feng ^a   Yen, Muh Yong ^a   Lin, Yi Ping ^a   Shih, Hsiu Chen ^a   Li, Lan Huei ^a   Chou, Pesus ^b   Deng, Chung Yeh ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BACTERIUM DETECTION; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DISEASE ASSOCIATION; DRUG SELF ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LUNG CAVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SPUTUM SMEAR; TAIWAN; UNEMPLOYMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84896728157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079644     Document Type: Article

References (31)

1. World Health Organization (1995) WHO report on the tuberculosis epidemic, 1995. Stop TB at the source. Geneva: WHO, 1995, Report No WHO/TB/95.183.
2. World Health Organization (2011) Global tuberculosis control. WHO report 2011. WHO/HTM/TB/2011.7. Geneva, Switzerland: WHO, 2011. Available: http://www.who.int/tb/publications/global-report/2011/en/index.html Accessed 2013 April.
3. Taiwan Centers for Disease Control and Prevention (2013) [Promulgated definitions of TB]. Taipei, Taiwan: CDC. Available: http://www.cdc.gov.tw/. Accessed 2013 Mar 31. [Chinese].
4. Volmink J, Garner P. (2009) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev: CD003343.
5. Wright J, Walley J, Philip A, Pushpananthan S, Dlamini E, et al. (2004) Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health 9: 559-565. (Pubitemid 38657280)
6. Wandwalo E, Kapalata N, Egwaga S, Morkve O (2004) Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis 8: 1248-1254. (Pubitemid 39371839)
7. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M (1998) Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352: 1340-1343. (Pubitemid 28510914)
8. MacIntyre CR, Goebel K, Brown GV, Skull S, Starr M, et al. (2003) A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting. Int J Tuberc Lung Dis 7: 848-854. (Pubitemid 37158423)
9. Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J, Sorensen HT (2002) Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 6: 389-395. (Pubitemid 34492162)
10. Frieden TR, Sbarbaro JA (2007) Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ 85: 407-409.
11. Mathema B, Pande SB, Jochem K, Houston RA, Smith I, et al. (2001) Tuberculosis treatment in nepal: a rapid assessment of government centers using different types of patient supervision. Int J Tuberc Lung Dis 5: 912-919. (Pubitemid 32976635)
12. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M (2000) A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. Int J Tuberc Lung Dis 4: 550-554. (Pubitemid 30409172)
13. Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nikolayevskyy V, et al. (2006) The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res 7: 44.
14. Waitt CJ, Squire SB (2011) A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 15: 871-885.
15. World Health Organization (1999) Global Tuberculosis Control. WHO Report 1999. Geneva, Switzerland, WHO/CDS/CPC/TB/99.259.
16. Department of Health (1971) Vital Statistics in Taiwan. Department of Health, Executive Yuan, Taiwan.
17. Lu TH, Lee MC, Chou MC (2000) Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 29: 336-343.
18. Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, et al. (2004) Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 170: 561-566. (Pubitemid 39209140)
19. Yen YF, Rodwell TC, Yen MY, Shih HC, Hu BS, et al. (2012) DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008. Int J Tuberc Lung Dis 16: 178-184.
20. Kim HJ, Lee CH, Shin S, Lee JH, Kim YW, et al. (2010) The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 79-85.
21. Anuwatnonthakate A, Limsomboon P, Nateniyom S, Wattanaamornkiat W, Komsakorn S, et al. (2008) Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS One 3: e3089.
22. Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, et al. (2009) Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five-year retrospective study. BMC Public Health 9: 371.
23. Kliiman K, Altraja A (2010) Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 454-463.
24. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, et al. (2011) Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis 11: 1.
25. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-725. (Pubitemid 44740086)
26. Falzon D, Le Strat Y, Belghiti F, Infuso A (2005) Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 9: 1224-1229. (Pubitemid 41735601)
27. Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, et al. (2008) The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 36: 335-340.
28. Chiang CY, Chang CT, Chang RE, Li CT, Huang RM (2005) Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis 9: 1006-1012.
29. Rao VK, Iademarco EP, Fraser VJ, Kollef MH (1998) The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 114: 1244-1252. (Pubitemid 28527393)
30. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988) Chest roentgenogram in pulmonary tuberculosis. New data on an old test. Chest 94: 316-320.
31. Lin HP, Deng CY, Chou P (2009) Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health 9: 55.